1887

Abstract

It has been reported that pathogenic are resistant to normal human serum (NHS) due to their ability to evade the complement immune system by interacting with factor H (FH) and C4b-binding protein (C4BP) regulators. Moreover, plasmin generation on the leptospiral surface diminishes C3b and IgG deposition, decreasing opsonophagocytosis by immune competent cells. We have previously reported that Lsa23 (LIC11360) is a multipurpose protein capable of binding purified extracellular matrix molecules, FH, C4BP and plasminogen (PLG)/plasmin in the presence of PLG activators. In this work, we provide further evidence that Lsa23 is located at the bacterial surface by using immunofluorescence microscopy. We show that Lsa23 has the ability to acquire FH, C4BP and PLG from NHS, and use these interactions to evade innate immunity. The binding with the complement regulators FH and C4BP preserves factor I (FI) activity, leading to C3b and C4b degradation products, respectively. C3b and C4b alpha-chain cleavage was also observed when Lsa23 bound to PLG generating plasmin, an effect blocked by the protease inhibitor aprotinin. Lsa23 also inhibited lytic activity by NHS mediated by both classical and alternative complement pathways. Thus, Lsa23 has the ability to block both pathways of the complement system, and may help pathogenic to escape complement-mediated clearance in human hosts. Indeed, NHS treated with Lsa23 confers a partial serum resistance phenotype to , whereas blocking this protein with anti-Lsa23 renders pathogenic more susceptible to complement-mediated killing. Thus, Lsa23 is a multifunctional protein involved in many pathways, featuring C4b cleavage by plasmin, knowledge that may help in the development of preventive approaches to intervene with human complement escape by this versatile pathogen.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000217
2016-02-01
2020-01-23
Loading full text...

Full text loading...

/deliver/fulltext/micro/162/2/295.html?itemId=/content/journal/micro/10.1099/mic.0.000217&mimeType=html&fmt=ahah

References

  1. Barbosa A. S., Abreu P. A., Vasconcellos S. A., Morais Z. M., Gonçales A. P., Silva A. S., Daha M. R., Isaac L.. 2009; Immune evasion of leptospira species by acquisition of human complement regulator C4BP. Infect Immun77:1137–1143 [CrossRef][PubMed]
    [Google Scholar]
  2. Barbosa A. S., Monaris D., Silva L. B., Morais Z. M., Vasconcellos S. A., Cianciarullo A. M., Isaac L., Abreu P. A.. 2010; Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun78:3207–3216 [CrossRef][PubMed]
    [Google Scholar]
  3. Barthel D., Schindler S., Zipfel P. F.. 2012a; Plasminogen is a complement inhibitor. J Biol Chem287:18831–18842 [CrossRef][PubMed]
    [Google Scholar]
  4. Barthel D., Singh B., Riesbeck K., Zipfel P. F.. 2012b; Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol188:379–385 [CrossRef][PubMed]
    [Google Scholar]
  5. Brissette C. A., Haupt K., Barthel D., Cooley A. E., Bowman A., Skerka C., Wallich R., Zipfel P. F., Kraiczy P., Stevenson B.. 2009; Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun77:300–306 [CrossRef][PubMed]
    [Google Scholar]
  6. Castiblanco-Valencia M. M., Fraga T. R., Silva L. B., Monaris D., Abreu P. A., Strobel S., Józsi M., Isaac L., Barbosa A. S.. 2012; Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J Infect Dis205:995–1004 [CrossRef][PubMed]
    [Google Scholar]
  7. Choy H. A.. 2012; Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement. PLoS One7:e41566 [CrossRef][PubMed]
    [Google Scholar]
  8. da Silva L. B., Miragaia L. S., Breda L. C., Abe C. M., Schmidt M. C., Moro A. M., Monaris D., Conde J. N., Józsi M., other authors. 2015; Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA. Infect Immun83:888–897 [CrossRef][PubMed]
    [Google Scholar]
  9. Domingos R. F., Vieira M. L., Romero E. C., Gonçales A. P., de Morais Z. M., Vasconcellos S. A., Nascimento A. L.. 2012; Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions. BMC Microbiol12:50 [CrossRef][PubMed]
    [Google Scholar]
  10. Guerreiro H., Croda J., Flannery B., Mazel M., Matsunaga J., Galvão Reis M., Levett P. N., Ko A. I., Haake D. A.. 2001; Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun69:4958–4968 [CrossRef][PubMed]
    [Google Scholar]
  11. Haake D. A., Chao G., Zuerner R. L., Barnett J. K., Barnett D., Mazel M., Matsunaga J., Levett P. N., Bolin C. A.. 2000; The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun68:2276–2285 [CrossRef][PubMed]
    [Google Scholar]
  12. Hallström T., Haupt K., Kraiczy P., Hortschansky P., Wallich R., Skerka C., Zipfel P. F.. 2010; Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. J Infect Dis202:490–498 [CrossRef][PubMed]
    [Google Scholar]
  13. Hallström T., Siegel C., Mörgelin M., Kraiczy P., Skerka C., Zipfel P. F.. 2013; CspA from Borrelia burgdorferi inhibits the terminal complement pathway. MBio4:e00481–e00413 [CrossRef][PubMed]
    [Google Scholar]
  14. Hammerschmidt C., Koenigs A., Siegel C., Hallström T., Skerka C., Wallich R., Zipfel P. F., Kraiczy P.. 2014; Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes. Infect Immun82:380–392 [CrossRef][PubMed]
    [Google Scholar]
  15. Hellwage J., Meri T., Heikkilä T., Alitalo A., Panelius J., Lahdenne P., Seppälä I. J., Meri S.. 2001; The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem276:8427–8435 [CrossRef][PubMed]
    [Google Scholar]
  16. Johnson R. C., Muschel L. H.. 1965; Antileptospiral activity of normal serum. J Bacteriol89:1625–1626[PubMed]
    [Google Scholar]
  17. Koch T. K., Reuter M., Barthel D., Böhm S., van den Elsen J., Kraiczy P., Zipfel P. F., Skerka C.. 2012; Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS One7:e47638 [CrossRef][PubMed]
    [Google Scholar]
  18. Koenigs A., Hammerschmidt C., Jutras B. L., Pogoryelov D., Barthel D., Skerka C., Kugelstadt D., Wallich R., Stevenson B., other authors. 2013; BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein. J Biol Chem288:25229–25243 [CrossRef][PubMed]
    [Google Scholar]
  19. Kraiczy P., Skerka C., Brade V., Zipfel P. F.. 2001; Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun69:7800–7809 [CrossRef][PubMed]
    [Google Scholar]
  20. Kraiczy P., Hellwage J., Skerka C., Kirschfink M., Brade V., Zipfel P. F., Wallich R.. 2003; Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol33:697–707 [CrossRef][PubMed]
    [Google Scholar]
  21. Law R. H., Abu-Ssaydeh D., Whisstock J. C.. 2013; New insights into the structure and function of the plasminogen/plasmin system. Curr Opin Struct Biol23:836–841 [CrossRef][PubMed]
    [Google Scholar]
  22. Livak K. J., Schmittgen T. D.. 2001; Analysis of relative gene expression data using real-time quantitative PCR and the 2( − Delta Delta CT) method. Methods25:402–408 [CrossRef][PubMed]
    [Google Scholar]
  23. McDowell J. V., Frederick J., Stamm L., Marconi R. T.. 2007; Identification of the gene encoding the FhbB protein of Treponema denticola, a highly unique factor H-like protein 1 binding protein. Infect Immun75:1050–1054 [CrossRef][PubMed]
    [Google Scholar]
  24. Meri T., Murgia R., Stefanel P., Meri S., Cinco M.. 2005; Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog39:139–147 [CrossRef][PubMed]
    [Google Scholar]
  25. Nakai K., Kanehisa M.. 1991; Expert system for predicting protein localization sites in Gram-negative bacteria. Proteins11:95–110 [CrossRef][PubMed]
    [Google Scholar]
  26. Picardeau M.. 2013; Diagnosis and epidemiology of leptospirosis. Med Mal Infect43:1–9 [CrossRef][PubMed]
    [Google Scholar]
  27. Pinne M., Haake D. A.. 2013; LipL32 is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS One8:e51025 [CrossRef][PubMed]
    [Google Scholar]
  28. Siegel C., Hallström T., Skerka C., Eberhardt H., Uzonyi B., Beckhaus T., Karas M., Wallich R., Stevenson B., other authors. 2010; Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLoS One5:e13519 [CrossRef][PubMed]
    [Google Scholar]
  29. Siqueira G. H., Atzingen M. V., Alves I. J., de Morais Z. M., Vasconcellos S. A., Nascimento A. L.. 2013; Characterization of three novel adhesins of Leptospira interrogans. Am J Trop Med Hyg89:1103–1116 [CrossRef][PubMed]
    [Google Scholar]
  30. Souza N. M., Vieira M. L., Alves I. J., de Morais Z. M., Vasconcellos S. A., Nascimento A. L.. 2012; Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog53:125–134 [CrossRef][PubMed]
    [Google Scholar]
  31. Teixeira A. F., de Morais Z. M., Kirchgatter K., Romero E. C., Vasconcellos S. A., Nascimento A. L.. 2015; Features of two new proteins with OmpA-like domains identified in the genome sequences of Leptospira interrogans. PLoS One10:e0122762 [CrossRef][PubMed]
    [Google Scholar]
  32. Turner L. H.. 1970; Leptospirosis. 3. Maintenance, isolation and demonstration of leptospires. Trans R Soc Trop Med Hyg64:623–646 [CrossRef][PubMed]
    [Google Scholar]
  33. Verma A., Hellwage J., Artiushin S., Zipfel P. F., Kraiczy P., Timoney J. F., Stevenson B.. 2006; LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun74:2659–2666 [CrossRef][PubMed]
    [Google Scholar]
  34. Vieira M. L., Nascimento A.L.T.O.. 2015; Interaction of spirochetes with the host fibrinolytic system and potential roles in pathogenesis. Crit Rev Microbiol Apr 27, 1–15 [Epub ahead of print] [CrossRef][PubMed]
    [Google Scholar]
  35. Vieira M. L., Vasconcellos S. A., Gonçales A. P., de Morais Z. M., Nascimento A. L.. 2009; Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun77:4092–4101 [CrossRef][PubMed]
    [Google Scholar]
  36. Vieira M. L., de Morais Z. M., Vasconcellos S. A., Romero E. C., Nascimento A. L.. 2011; In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb Pathog51:360–365 [CrossRef][PubMed]
    [Google Scholar]
  37. Vieira M. L., Atzingen M. V., Oliveira R., Mendes R. S., Domingos R. F., Vasconcellos S. A., Nascimento A. L.. 2012; Plasminogen binding proteins and plasmin generation on the surface of Leptospira spp.: the contribution to the bacteria-host interactions. J Biomed Biotechnol2012:758513 [CrossRef][PubMed]
    [Google Scholar]
  38. Wolff D. G., Castiblanco-Valencia M. M., Abe C. M., Monaris D., Morais Z. M., Souza G. O., Vasconcellos S. A., Isaac L., Abreu P. A., Barbosa A. S.. 2013; Interaction of Leptospira elongation factor Tu with plasminogen and complement factor H: a metabolic leptospiral protein with moonlighting activities. PLoS One8:e81818 [CrossRef][PubMed]
    [Google Scholar]
  39. Zipfel P. F., Hallström T., Riesbeck K.. 2013; Human complement control and complement evasion by pathogenic microbes–tipping the balance. Mol Immunol56:152–160 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000217
Loading
/content/journal/micro/10.1099/mic.0.000217
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error